Altered thymidine metabolism due to defects of thymidine phosphorylase
- PMID: 11733540
- DOI: 10.1074/jbc.M111028200
Altered thymidine metabolism due to defects of thymidine phosphorylase
Abstract
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive human disease due to mutations in the thymidine phosphorylase (TP) gene. TP enzyme catalyzes the reversible phosphorolysis of thymidine to thymine and 2-deoxy-D-ribose 1-phosphate. We present evidence that thymidine metabolism is altered in MNGIE. TP activities in buffy coats were reduced drastically in all 27 MNGIE patients compared with 19 controls. All MNGIE patients had much higher plasma levels of thymidine than normal individuals and asymptomatic TP mutation carriers. In two patients, the renal clearance of thymidine was approximately 20% that of creatinine, and because hemodialysis demonstrated that thymidine is ultrafiltratable, most of the filtered thymidine is likely to be reabsorbed by the kidney. In vitro, fibroblasts from controls catabolized thymidine in medium; by contrast, MNGIE fibroblasts released thymidine. In MNGIE, severe impairment of TP enzyme activity leads to increased plasma thymidine. In patients who are suspected of having MNGIE, determination of TP activity in buffy coats and thymidine levels in plasma are diagnostic. We hypothesize that excess thymidine alters mitochondrial nucleoside and nucleotide pools leading to impaired mitochondrial DNA replication, repair, or both. Therapies to reduce thymidine levels may be beneficial to MNGIE patients.
Similar articles
-
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes.Neurologist. 2004 Jan;10(1):8-17. doi: 10.1097/01.nrl.0000106919.06469.04. Neurologist. 2004. PMID: 14720311 Review.
-
Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations.Ann Neurol. 2000 Jun;47(6):792-800. Ann Neurol. 2000. PMID: 10852545
-
Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder.Science. 1999 Jan 29;283(5402):689-92. doi: 10.1126/science.283.5402.689. Science. 1999. PMID: 9924029
-
Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays.Clin Chem. 2004 Jan;50(1):120-4. doi: 10.1373/clinchem.2003.026179. Epub 2003 Nov 18. Clin Chem. 2004. PMID: 14633909
-
MNGIE: from nuclear DNA to mitochondrial DNA.Neuromuscul Disord. 2001 Jan;11(1):7-10. doi: 10.1016/s0960-8966(00)00159-0. Neuromuscul Disord. 2001. PMID: 11166160 Review.
Cited by
-
Emerging therapies for mitochondrial disorders.Brain. 2016 Jun;139(Pt 6):1633-48. doi: 10.1093/brain/aww081. Epub 2016 May 3. Brain. 2016. PMID: 27190030 Free PMC article. Review.
-
Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity.Methods Mol Biol. 2012;837:121-33. doi: 10.1007/978-1-61779-504-6_8. Methods Mol Biol. 2012. PMID: 22215544 Free PMC article.
-
Progressive external ophthalmoplegia.Handb Clin Neurol. 2023;194:9-21. doi: 10.1016/B978-0-12-821751-1.00018-X. Handb Clin Neurol. 2023. PMID: 36813323 Free PMC article. Review.
-
Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy.Neurogastroenterol Motil. 2009 Jun;21(6):627-31. doi: 10.1111/j.1365-2982.2009.01264.x. Epub 2009 Mar 12. Neurogastroenterol Motil. 2009. PMID: 19368660 Free PMC article.
-
Inborn errors of pyrimidine metabolism: clinical update and therapy.J Inherit Metab Dis. 2014 Sep;37(5):687-98. doi: 10.1007/s10545-014-9742-3. Epub 2014 Jul 17. J Inherit Metab Dis. 2014. PMID: 25030255
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources